Sysmex, a leading company headquartered in Japan, develops and distributes innovative medical technology products and laboratory diagnostics solutions. Their focus is on hematology, urinalysis, and coagulation systems. Sysmex supports healthcare professionals globally with precise diagnostic systems, reagents, and software to optimize patient care.
Date confirmed from the Tokyo Stock Exchange (JPX) announcement schedule.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Sysmex is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Sysmex last reported quarterly earnings on 8/7/2026 (Q2 2026). Earnings per share (EPS) came in at 14.17 JPY.
Across its last 5 earnings reports, Sysmex stock moved by ±1.6% on average the following day. The largest reaction was +3.4% on 02/12/2026; 4 of 5 reactions were positive.
Sysmex has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.